טוען...
In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [(18)F]flutemetamol
BACKGROUND: The purpose of the study was to evaluate the applicability of (18)F-labelled amyloid imaging positron emission tomography (PET) agent [(18)F]flutemetamol to detect changes in brain beta-amyloid (Aβ) deposition in vivo in APP23, Tg2576 and APPswe-PS1dE9 mouse models of Alzheimer's di...
שמור ב:
| הוצא לאור ב: | EJNMMI Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4412375/ https://ncbi.nlm.nih.gov/pubmed/25977876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-014-0037-3 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|